Esperion Therapeutics (ESPR) Earnings Date & Reports

Esperion Therapeutics Inc is a commercial-stage biopharmaceutical company currently focused on bringing new medicines to patients that address unmet medical needs... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

ESPR is expected to report earnings to fall 98.60% to 0 cents per share on August 04

Esperion Therapeutics ESPR Stock Earnings Reports

Q2'26

Est.

$0.00

Q1'26

Missed

by $0.08

Q4'25

Missed

by $0.07

Q3'25

Missed

by $0.18

Q2'25

Beat

by $0.12

The last earnings report on May 08 showed earnings per share of -10 cents, missing the estimate of -2 cents. With 11.23M shares outstanding, the current market capitalization sits at 811.73M.

View a ticker or compare two or three

Compare

ESPR

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for ESPR